The evaluation of granulated excipients as matrix material for controlled delivery of captopril

Hsiu O. Ho, Han Yen Wang, Ming Thau Sheu

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Granulated excipients of lactose or dicalcium phosphate with ethylcellulose were examined for their ability to be used as matrix materials to produce a controlled release dosage form by direct compression for captopril. The physical characteristics of both granulated excipients and their resulting tablets were evaluated. It was found necessary to add hydroxy propylmethylcellulose (HPMC) to improve the cohesion of granulated excipients. The hydrophobic nature of ethylcelullose possibly hindered the release of captopril from all these matrix formulations. However, controllability of the in vitro release of captopril in lactose formulations appeared to be much better than that in dicalcium phosphate formulations Three lactose tablet formulations with distinguishable in vitro dissolution rates were selected and compared with Capoten® for their in vivo sustainability of captopril release. The results demonstrated that the bioavailability of each of these matrix formulations was less than that of the immediate release product of Capoten®. The C(max) was lower and T(max) longer for the matrix formulations tested indicating the sustainability of captopril release from matrix tablets using granulated excipients as a directly-compressible matrix material.

Original languageEnglish
Pages (from-to)243-251
Number of pages9
JournalJournal of Controlled Release
Volume49
Issue number2-3
DOIs
Publication statusPublished - Dec 15 1997

Fingerprint

Excipients
Captopril
Lactose
Tablets
Dosage Forms
Biological Availability

Keywords

  • Captopril
  • Dicalcium phosphate
  • Ethylcellulose
  • Granulated excipients
  • Lactose
  • Matrix tablet

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

The evaluation of granulated excipients as matrix material for controlled delivery of captopril. / Ho, Hsiu O.; Wang, Han Yen; Sheu, Ming Thau.

In: Journal of Controlled Release, Vol. 49, No. 2-3, 15.12.1997, p. 243-251.

Research output: Contribution to journalArticle

@article{d69c64ab362143b187c533501a9b4d19,
title = "The evaluation of granulated excipients as matrix material for controlled delivery of captopril",
abstract = "Granulated excipients of lactose or dicalcium phosphate with ethylcellulose were examined for their ability to be used as matrix materials to produce a controlled release dosage form by direct compression for captopril. The physical characteristics of both granulated excipients and their resulting tablets were evaluated. It was found necessary to add hydroxy propylmethylcellulose (HPMC) to improve the cohesion of granulated excipients. The hydrophobic nature of ethylcelullose possibly hindered the release of captopril from all these matrix formulations. However, controllability of the in vitro release of captopril in lactose formulations appeared to be much better than that in dicalcium phosphate formulations Three lactose tablet formulations with distinguishable in vitro dissolution rates were selected and compared with Capoten{\circledR} for their in vivo sustainability of captopril release. The results demonstrated that the bioavailability of each of these matrix formulations was less than that of the immediate release product of Capoten{\circledR}. The C(max) was lower and T(max) longer for the matrix formulations tested indicating the sustainability of captopril release from matrix tablets using granulated excipients as a directly-compressible matrix material.",
keywords = "Captopril, Dicalcium phosphate, Ethylcellulose, Granulated excipients, Lactose, Matrix tablet",
author = "Ho, {Hsiu O.} and Wang, {Han Yen} and Sheu, {Ming Thau}",
year = "1997",
month = "12",
day = "15",
doi = "10.1016/S0168-3659(97)00093-X",
language = "English",
volume = "49",
pages = "243--251",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - The evaluation of granulated excipients as matrix material for controlled delivery of captopril

AU - Ho, Hsiu O.

AU - Wang, Han Yen

AU - Sheu, Ming Thau

PY - 1997/12/15

Y1 - 1997/12/15

N2 - Granulated excipients of lactose or dicalcium phosphate with ethylcellulose were examined for their ability to be used as matrix materials to produce a controlled release dosage form by direct compression for captopril. The physical characteristics of both granulated excipients and their resulting tablets were evaluated. It was found necessary to add hydroxy propylmethylcellulose (HPMC) to improve the cohesion of granulated excipients. The hydrophobic nature of ethylcelullose possibly hindered the release of captopril from all these matrix formulations. However, controllability of the in vitro release of captopril in lactose formulations appeared to be much better than that in dicalcium phosphate formulations Three lactose tablet formulations with distinguishable in vitro dissolution rates were selected and compared with Capoten® for their in vivo sustainability of captopril release. The results demonstrated that the bioavailability of each of these matrix formulations was less than that of the immediate release product of Capoten®. The C(max) was lower and T(max) longer for the matrix formulations tested indicating the sustainability of captopril release from matrix tablets using granulated excipients as a directly-compressible matrix material.

AB - Granulated excipients of lactose or dicalcium phosphate with ethylcellulose were examined for their ability to be used as matrix materials to produce a controlled release dosage form by direct compression for captopril. The physical characteristics of both granulated excipients and their resulting tablets were evaluated. It was found necessary to add hydroxy propylmethylcellulose (HPMC) to improve the cohesion of granulated excipients. The hydrophobic nature of ethylcelullose possibly hindered the release of captopril from all these matrix formulations. However, controllability of the in vitro release of captopril in lactose formulations appeared to be much better than that in dicalcium phosphate formulations Three lactose tablet formulations with distinguishable in vitro dissolution rates were selected and compared with Capoten® for their in vivo sustainability of captopril release. The results demonstrated that the bioavailability of each of these matrix formulations was less than that of the immediate release product of Capoten®. The C(max) was lower and T(max) longer for the matrix formulations tested indicating the sustainability of captopril release from matrix tablets using granulated excipients as a directly-compressible matrix material.

KW - Captopril

KW - Dicalcium phosphate

KW - Ethylcellulose

KW - Granulated excipients

KW - Lactose

KW - Matrix tablet

UR - http://www.scopus.com/inward/record.url?scp=0031475142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031475142&partnerID=8YFLogxK

U2 - 10.1016/S0168-3659(97)00093-X

DO - 10.1016/S0168-3659(97)00093-X

M3 - Article

AN - SCOPUS:0031475142

VL - 49

SP - 243

EP - 251

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 2-3

ER -